{
 "name": "CTEM Program Starter questions",
 "publisher": "CTEM Vendors",
 "url": "https://ctemvendors.com/datasets/",
 "read": "2026-11-12",
 "license": "CC BY 4.0",
 "cite": "CTEM Vendors, CTEM Program Starter questions, read 12 Nov 2026, https://ctemvendors.com/datasets/",
 "rows": [
  {
   "phase": "Scope the first cycle",
   "stage": "scoping",
   "days": "Days 1 to 15",
   "n": 1,
   "question": "Can your product hold a scope definition by business service rather than by IP range, and can you show it in a demo on our asset data?"
  },
  {
   "phase": "Scope the first cycle",
   "stage": "scoping",
   "days": "Days 1 to 15",
   "n": 2,
   "question": "Which document URL describes how a user tags assets with business criticality, and can the tags be imported from our CMDB?"
  },
  {
   "phase": "Scope the first cycle",
   "stage": "scoping",
   "days": "Days 1 to 15",
   "n": 3,
   "question": "Can you show a sample report that groups exposures by business service and owner, not only by severity?"
  },
  {
   "phase": "Scope the first cycle",
   "stage": "scoping",
   "days": "Days 1 to 15",
   "n": 4,
   "question": "Which regulatory or framework mappings (NIST CSF 2.0, PCI DSS, DORA) do your reports include, and where is each documented?"
  },
  {
   "phase": "Scope the first cycle",
   "stage": "scoping",
   "days": "Days 1 to 15",
   "n": 5,
   "question": "How does a scope change (a new subsidiary, a new cloud account) appear in the product, and is the change logged with a date?"
  },
  {
   "phase": "Scope the first cycle",
   "stage": "scoping",
   "days": "Days 1 to 15",
   "n": 6,
   "question": "Can a scope be limited to the external surface or a single SaaS estate for a pilot, and what does the license cost for that limited scope?"
  },
  {
   "phase": "Scope the first cycle",
   "stage": "scoping",
   "days": "Days 1 to 15",
   "n": 7,
   "question": "Which named customer reference ran a first cycle on a similar scope, and can we speak to them?"
  },
  {
   "phase": "Discover assets and exposures in scope",
   "stage": "discovery",
   "days": "Days 10 to 30",
   "n": 1,
   "question": "Which of the four surfaces (cloud, on-premises and endpoints, identity, external) does your product discover natively, and which only through an integration? Please send the document URL for each."
  },
  {
   "phase": "Discover assets and exposures in scope",
   "stage": "discovery",
   "days": "Days 10 to 30",
   "n": 2,
   "question": "Can you run discovery on our scope during the trial and show which assets you found that our current scanners did not?"
  },
  {
   "phase": "Discover assets and exposures in scope",
   "stage": "discovery",
   "days": "Days 10 to 30",
   "n": 3,
   "question": "Which named scanner integrations (for example Tenable, Qualys, Rapid7, Microsoft Defender) do you ingest, and is each listed on a public integrations page?"
  },
  {
   "phase": "Discover assets and exposures in scope",
   "stage": "discovery",
   "days": "Days 10 to 30",
   "n": 4,
   "question": "How do you deduplicate one asset reported by three tools, and can you show the merge rule in your documentation?"
  },
  {
   "phase": "Discover assets and exposures in scope",
   "stage": "discovery",
   "days": "Days 10 to 30",
   "n": 5,
   "question": "Does your product find identity exposures such as excess privileges or stale accounts, and where is that documented?"
  },
  {
   "phase": "Discover assets and exposures in scope",
   "stage": "discovery",
   "days": "Days 10 to 30",
   "n": 6,
   "question": "How often does discovery rerun, and can we set the cadence per scope?"
  },
  {
   "phase": "Discover assets and exposures in scope",
   "stage": "discovery",
   "days": "Days 10 to 30",
   "n": 7,
   "question": "Can every finding be traced back to the tool and date that produced it in an export we can keep?"
  },
  {
   "phase": "Prioritize on evidence",
   "stage": "prioritization",
   "days": "Days 25 to 45",
   "n": 1,
   "question": "Which inputs does your ranking use (validation results, threat intelligence including CISA KEV, asset criticality, reachability, compensating controls), and where is each input documented?"
  },
  {
   "phase": "Prioritize on evidence",
   "stage": "prioritization",
   "days": "Days 25 to 45",
   "n": 2,
   "question": "Can you show the ranking for one of our exposures and explain every factor that moved it up or down?"
  },
  {
   "phase": "Prioritize on evidence",
   "stage": "prioritization",
   "days": "Days 25 to 45",
   "n": 3,
   "question": "Does your ranking use results from your own testing, or does it infer exploitability from threat intelligence alone?"
  },
  {
   "phase": "Prioritize on evidence",
   "stage": "prioritization",
   "days": "Days 25 to 45",
   "n": 4,
   "question": "How quickly does a new CISA KEV entry change the ranking in the product, and can you show the update log?"
  },
  {
   "phase": "Prioritize on evidence",
   "stage": "prioritization",
   "days": "Days 25 to 45",
   "n": 5,
   "question": "Can we override a priority with a reason and keep that override in the audit trail?"
  },
  {
   "phase": "Prioritize on evidence",
   "stage": "prioritization",
   "days": "Days 25 to 45",
   "n": 6,
   "question": "Can you show a sample report where compensating controls lowered the priority of a finding, with the control named?"
  },
  {
   "phase": "Prioritize on evidence",
   "stage": "prioritization",
   "days": "Days 25 to 45",
   "n": 7,
   "question": "What share of findings in a typical customer scope ends on the priority list, and is that figure published or only stated in a sales call?"
  },
  {
   "phase": "Validate what is exploitable here",
   "stage": "validation",
   "days": "Days 40 to 60",
   "n": 1,
   "question": "Which validation methods does your own product run (attack simulation, automated penetration testing, control testing), and what is the document URL for each?"
  },
  {
   "phase": "Validate what is exploitable here",
   "stage": "validation",
   "days": "Days 40 to 60",
   "n": 2,
   "question": "Can you run a safe test on one of our priority items during the trial and show the result per control?"
  },
  {
   "phase": "Validate what is exploitable here",
   "stage": "validation",
   "days": "Days 40 to 60",
   "n": 3,
   "question": "How do you show an attack path to a critical asset, and is the path proven by a test or inferred from configuration data?"
  },
  {
   "phase": "Validate what is exploitable here",
   "stage": "validation",
   "days": "Days 40 to 60",
   "n": 4,
   "question": "Which ATT&CK version is your content mapped to, and how many weeks after a new ATT&CK release is the mapping updated?"
  },
  {
   "phase": "Validate what is exploitable here",
   "stage": "validation",
   "days": "Days 40 to 60",
   "n": 5,
   "question": "How often is your attack or threat library updated, and where is the change log published?"
  },
  {
   "phase": "Validate what is exploitable here",
   "stage": "validation",
   "days": "Days 40 to 60",
   "n": 6,
   "question": "Can a fixed item be re-tested automatically, and can you show a before and after report?"
  },
  {
   "phase": "Validate what is exploitable here",
   "stage": "validation",
   "days": "Days 40 to 60",
   "n": 7,
   "question": "What safety controls stop a test from affecting production, and are they documented publicly?"
  },
  {
   "phase": "Validate what is exploitable here",
   "stage": "validation",
   "days": "Days 40 to 60",
   "n": 8,
   "question": "Does any validation depend on a partner product, and which one?"
  },
  {
   "phase": "Mobilize the fix",
   "stage": "mobilization",
   "days": "Days 50 to 75",
   "n": 1,
   "question": "Which ticketing and workflow integrations (ServiceNow, Jira, others) are named on your public integrations page, and are they two-way?"
  },
  {
   "phase": "Mobilize the fix",
   "stage": "mobilization",
   "days": "Days 50 to 75",
   "n": 2,
   "question": "Can you show remediation guidance for one of our validated exposures as it would appear in a ticket?"
  },
  {
   "phase": "Mobilize the fix",
   "stage": "mobilization",
   "days": "Days 50 to 75",
   "n": 3,
   "question": "Does your product produce mitigation content for the controls we already run (EDR rules, SIEM detections, IPS signatures), and for which named products?"
  },
  {
   "phase": "Mobilize the fix",
   "stage": "mobilization",
   "days": "Days 50 to 75",
   "n": 4,
   "question": "Can a ticket close automatically only after a passing re-test, and where is that documented?"
  },
  {
   "phase": "Mobilize the fix",
   "stage": "mobilization",
   "days": "Days 50 to 75",
   "n": 5,
   "question": "How does your product track due dates and SLA breaches by owner, and can you show a sample report?"
  },
  {
   "phase": "Mobilize the fix",
   "stage": "mobilization",
   "days": "Days 50 to 75",
   "n": 6,
   "question": "Can a risk acceptance be recorded with an approver and an expiry date?"
  },
  {
   "phase": "Mobilize the fix",
   "stage": "mobilization",
   "days": "Days 50 to 75",
   "n": 7,
   "question": "Which automated response actions can the product take, and which need human approval?"
  },
  {
   "phase": "Measure, report and scope cycle two",
   "stage": "review",
   "days": "Days 76 to 90",
   "n": 1,
   "question": "Can your product produce a board-level report that shows trend by business service across cycles, and can you share a sample?"
  },
  {
   "phase": "Measure, report and scope cycle two",
   "stage": "review",
   "days": "Days 76 to 90",
   "n": 2,
   "question": "Which measures does the product calculate out of the box (time to verified fix, validated exposures closed, control detection rate), and how is each defined in the documentation?"
  },
  {
   "phase": "Measure, report and scope cycle two",
   "stage": "review",
   "days": "Days 76 to 90",
   "n": 3,
   "question": "Can we export all results and evidence in an open format if we leave the product?"
  },
  {
   "phase": "Measure, report and scope cycle two",
   "stage": "review",
   "days": "Days 76 to 90",
   "n": 4,
   "question": "How does the product compare one cycle with the next when the scope changes?"
  },
  {
   "phase": "Measure, report and scope cycle two",
   "stage": "review",
   "days": "Days 76 to 90",
   "n": 5,
   "question": "What did the customer reference you named in scoping report to its board after its first cycle?"
  },
  {
   "phase": "Measure, report and scope cycle two",
   "stage": "review",
   "days": "Days 76 to 90",
   "n": 6,
   "question": "Which of the five stages does your roadmap say will change in the next two releases, and is the roadmap published?"
  }
 ]
}
